LATOYA COWARD: Open Payments
NPI 1184903023 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,189 in 134 payments from 16 companies in 2025. Trend: 2023 $2,609 · 2024 $1,762 · 2025 $2,189
Food & beverage: $2,189
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $687 |
| PFIZER INC. | 20 | $261 |
| Novo Nordisk Inc | 19 | $246 |
| ABBVIE INC. | 13 | $156 |
| Amgen Inc. | 14 | $151 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $148 |
| Otsuka America Pharmaceutical, Inc. | 7 | $135 |
| Lundbeck LLC | 5 | $95 |
| Astellas Pharma US Inc | 3 | $61 |
| Lilly USA, LLC | 4 | $56 |
Products named: BREZTRI, AIRSUPRA, REXULTI, NURTEC ODT, TRINTELLIX, FARXIGA, Wegovy, VRAYLAR.
Industry payments across AR — which companies pay providers there.
